For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230504:nRSD4611Ya&default-theme=true
RNS Number : 4611Y Arix Bioscience Plc 04 May 2023
Arix Bioscience plc
("Company")
PDMR notifications & Director Shareholdings
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.
The Company has been notified that Debra Barker, Non-Executive Director and
Senior Independent Director purchased 26,000 Ordinary shares of 0.001 pence
each in the Company ("Shares") on 03 May 2023 at a price of 106 pence per
share.
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Debra Barker
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Arix Bioscience plc
b) LEI 213800OVT3AHQCXNIX43
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Arix Bioscience plc Ordinary shares of 0.001 pence each
Identification code GB00BD045071
b) Nature of the transaction Share purchase
c) Price(s) and volume(s) Price(s) £ Volume(s)
£1.06.00 26,000
d) Aggregated information
- Aggregated volume N/A (single transaction)
- Price £27,560.00
e) Date of the transaction 03 May
2023
f) Place of the transaction London Stock Exchange
For further information please contact:
Kin Company Secretarial Limited, Company Secretary
+44 20 8819 6486
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFZLFBXELFBBZ